<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03799939</url>
  </required_header>
  <id_info>
    <org_study_id>305/2018</org_study_id>
    <nct_id>NCT03799939</nct_id>
  </id_info>
  <brief_title>Chimney Trial of Parastomal Hernia Prevention</brief_title>
  <official_title>Chimney Trial - Randomized, Controlled, Multi Center Trial of Parastomal Hernia Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chimney trial is designed to compare the effectiveness and safety of specifically designated&#xD;
      polyvinylidene fluoride mesh (PVDF, Dynamesh IPST) to controls in a multi center, randomized&#xD;
      setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The European Hernia Society recommends the use of prophylactic mesh when permanent colostomy&#xD;
      is made. The results of previous trials using keyhole technique are partially unsatisfactory.&#xD;
      Specifically designed PVDF mesh used in this trial showed promising results in previous small&#xD;
      trial.&#xD;
&#xD;
      Chimney trial is designed to compare the effectiveness and safety of mesh group to controls&#xD;
      operated with no preventive mesh in parastomal hernia prevention after laparoscopic or&#xD;
      robotic-assisted abdominoperineal resection or low Haartman's procedure for rectal&#xD;
      adenocarcinoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 5, 2019</start_date>
  <completion_date type="Anticipated">July 2026</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Chimney trial is a prospective randomized controlled multicenter trial.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants are unaware of the randomization group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of parastomal hernia</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of parastomal hernia at 12 months follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of parastomal hernia at long term follow up</measure>
    <time_frame>5 years</time_frame>
    <description>Incidence of parastomal hernia during 5 years of follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection rate</measure>
    <time_frame>30 days</time_frame>
    <description>Surgical site infections measured by Clavien-Dindo Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications measured by Clavien-Dindo Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stoma related complications</measure>
    <time_frame>5 years</time_frame>
    <description>Stoma related complications measured by Clavien-Dindo Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation rate</measure>
    <time_frame>5 years</time_frame>
    <description>Need for reoperations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
    <description>Operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay at the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rand 36 quality of life</measure>
    <time_frame>5 years</time_frame>
    <description>Quality of life measured by Rand-36 quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life measured by Colostomy impact score</measure>
    <time_frame>5 years</time_frame>
    <description>Quality of life measured by Colostomy impact score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medico-economic substudy</measure>
    <time_frame>5 years</time_frame>
    <description>Medico-economic substudy including both short and long term costs included in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological substudy of stoma distance</measure>
    <time_frame>3 years</time_frame>
    <description>Distance of stoma from midline defined by umbilicus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological substudy of adipose tissue thickness</measure>
    <time_frame>3 years</time_frame>
    <description>Thickness of adipose tissue on computer tomography scan on contralateral site of stoma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">141</enrollment>
  <condition>Parastomal Hernia</condition>
  <condition>Rectal Adenocarcinoma</condition>
  <condition>Abdominoperineal Resection</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyvinylidene fluoride mesh used in this trial (Dynamesh IPST) is synthetic mesh with central tube to accommodate bowel tightly and designed to prevent and treat parastomal hernia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in control group are operated with no preventive mesh.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention group</intervention_name>
    <description>Polyvinylidene fluoride mesh (Dynamesh IPST) is used on intraperitoneal onlay position to prevent parastomal hernia.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Rectal adenocarcinoma with curative intent laparoscopic or robotic assisted&#xD;
             abdominoperineal resection or low Hartmann´s operation and permanent colostomy&#xD;
&#xD;
          -  Patient has a life expectancy of at least 12 months.&#xD;
&#xD;
          -  Patient must sign Informed consent before any study procedures and agrees to attend&#xD;
             all study visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abdominoperineal resection or Hartmann's operation by laparotomy or conversion to&#xD;
             laparotomy&#xD;
&#xD;
          -  Complication requiring laparotomy during post surgery treatment at surgical ward after&#xD;
             APR&#xD;
&#xD;
          -  Patient with a comorbid illness or condition that would preclude the use of surgery&#xD;
             (ASA 4-5).&#xD;
&#xD;
          -  Patients with concurrent or previous malignant tumors within 5 years before study&#xD;
             enrollment&#xD;
&#xD;
          -  Patients with T4b tumors which impose a multi-organ resection&#xD;
&#xD;
          -  Rectal malignancy other than adenocarcinoma&#xD;
&#xD;
          -  Patient undergoing emergency procedures&#xD;
&#xD;
          -  Planned rectal surgery along with major concomitant procedures (e.g. hepatectomies,&#xD;
             other intestinal resections).&#xD;
&#xD;
          -  Metastatic disease with no possibility of curative surgery&#xD;
&#xD;
          -  Pregnant or suspected pregnancy&#xD;
&#xD;
          -  Patients living geographically distant and/or unwilling to return for follow-ups or&#xD;
             comply with all study requirements&#xD;
&#xD;
          -  Active abdominal infection at the time of surgery&#xD;
&#xD;
          -  Previous surgery at the colostomy site&#xD;
&#xD;
          -  Language barrier or other reasons why informed consent is not possible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keski-Suomi Central Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maziar Nikberg</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 6, 2019</study_first_submitted>
  <study_first_submitted_qc>January 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2019</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Elisa Makarainen-Uhlback</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

